| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.048 | 0.8 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |